BTG3 and Alzheimer disease: Screening tests detect antinuclear antibodies (ANA), followed by anti‐double stranded DNA (anti‐dsDNA) antibodies and anti‐extractable nuclear antigen antibodies (anti‐ENA), which are generally highly specific for confirmation of a type of AD.